Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 24

1.

Pre-Transplantation Immune Cell Distribution and Early Post-Transplant Fungal Infection Are the Main Risk Factors of Liver Transplantation Recipients in Lower Model of End-Stage Liver Disease.

Abdelhamid NM, Chen YC, Wang YC, Cheng CH, Wu TJ, Lee CF, Wu TH, Chou HS, Chan KM, Lee WC, Soong RS.

Transplant Proc. 2017 Jan - Feb;49(1):92-97. doi: 10.1016/j.transproceed.2016.11.014.

2.

Application of CD8+ Cells Count as a Guide of Immunosuppressive Regimen Introduction for Very Sick Patients Undergoing Liver Transplantation.

Lee CF, Wang YC, Cheng CH, Wu TH, Chen YC, Soong RS, Wu TJ, Chou HS, Chan KM, Lee WC.

Transplant Proc. 2016 Dec;48(10):3356-3361. doi: 10.1016/j.transproceed.2016.09.038.

PMID:
27931581
3.

Effect of Prophylactic Antifungal Protocols on the Prognosis of Liver Transplantation: A Propensity Score Matching and Multistate Model Approach.

Chen YC, Huang TS, Wang YC, Cheng CH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC, Soong RS.

Biomed Res Int. 2016;2016:6212503. Epub 2016 Sep 26.

4.

RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.

Soong RS, Anchoori RK, Yang B, Yang A, Tseng SH, He L, Tsai YC, Roden RB, Hung CF.

Oncotarget. 2016 Oct 18;7(42):68489-68502. doi: 10.18632/oncotarget.12095.

5.

Betel quid chewing leads to the development of unique de novo malignancies in liver transplant recipients, a retrospective single center study in Taiwan.

Chen YC, Cheng CH, Wang YC, Wu TJ, Chou HS, Chan KM, Lee WC, Lee CF, Soong RS.

Medicine (Baltimore). 2016 Sep;95(37):e4901. doi: 10.1097/MD.0000000000004901.

6.

Validation of the Model for End-Stage Liver Disease Score Criteria in Urgent Liver Transplantation for Acute Flare Up of Hepatitis B.

Lee WC, Lee CS, Wang YC, Cheng CH, Wu TH, Lee CF, Soong RS, Chang ML, Wu TJ, Chou HS, Chan KM.

Medicine (Baltimore). 2016 May;95(22):e3609. doi: 10.1097/MD.0000000000003609.

7.

Adult Living Donor Liver Transplantation Across ABO-Incompatibility.

Lee CF, Cheng CH, Wang YC, Soong RS, Wu TH, Chou HS, Wu TJ, Chan KM, Lee CS, Lee WC.

Medicine (Baltimore). 2015 Oct;94(42):e1796. doi: 10.1097/MD.0000000000001796.

8.

Outcomes of liver resection for hepatocellular carcinoma in liver transplantation era.

Lee WC, Lee CF, Cheng CH, Wu TJ, Chou HS, Wu TH, Soong RS, Chan KM, Yu MC, Chen MF.

Eur J Surg Oncol. 2015 Sep;41(9):1144-52. doi: 10.1016/j.ejso.2015.05.024. Epub 2015 Jun 23.

PMID:
26163047
9.

Effects of converting tacrolimus formulation from twice-daily to once-daily in liver transplantation recipients.

Thorat A, Chou HS, Lee CF, Soong RS, Wu TH, Cheng CH, Wu TJ, Chan KM, Lee WC.

Biomed Res Int. 2014;2014:265658. doi: 10.1155/2014/265658. Epub 2014 Jul 14.

10.

Toll-like receptor agonist imiquimod facilitates antigen-specific CD8+ T-cell accumulation in the genital tract leading to tumor control through IFNγ.

Soong RS, Song L, Trieu J, Knoff J, He L, Tsai YC, Huh W, Chang YN, Cheng WF, Roden RB, Wu TC, Trimble CL, Hung CF.

Clin Cancer Res. 2014 Nov 1;20(21):5456-67. doi: 10.1158/1078-0432.CCR-14-0344. Epub 2014 Jun 3.

11.

Direct T cell activation via CD40 ligand generates high avidity CD8+ T cells capable of breaking immunological tolerance for the control of tumors.

Soong RS, Song L, Trieu J, Lee SY, He L, Tsai YC, Wu TC, Hung CF.

PLoS One. 2014 Mar 24;9(3):e93162. doi: 10.1371/journal.pone.0093162. eCollection 2014.

12.

Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.

Lee SY, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC.

J Mol Med (Berl). 2013 Oct;91(10):1221-31. doi: 10.1007/s00109-013-1054-9. Epub 2013 May 29.

13.

Intratumoral injection of therapeutic HPV vaccinia vaccine following cisplatin enhances HPV-specific antitumor effects.

Lee SY, Kang TH, Knoff J, Huang Z, Soong RS, Alvarez RD, Hung CF, Wu TC.

Cancer Immunol Immunother. 2013 Jul;62(7):1175-85. doi: 10.1007/s00262-013-1421-y. Epub 2013 Apr 25.

14.

Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53.

Soong RS, Trieu J, Lee SY, He L, Tsai YC, Wu TC, Hung CF.

PLoS One. 2013;8(2):e56912. doi: 10.1371/journal.pone.0056912. Epub 2013 Feb 15.

15.

Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era.

Lee WC, Chan KM, Chou HS, Wu TJ, Lee CF, Soong RS, Wu TH, Lee CS.

Ann Surg. 2013 Aug;258(2):306-11. doi: 10.1097/SLA.0b013e3182754b8e.

PMID:
23108123
16.

A late recurring and easily forgotten tumor: ovarian granulosa cell tumor.

Chen YC, Chang LC, Soong RS.

World J Surg Oncol. 2012 May 16;10:85. doi: 10.1186/1477-7819-10-85.

17.

The risk factors for early infection in adult living donor liver transplantation recipients.

Soong RS, Chan KM, Chou HS, Wu TJ, Lee CF, Wu TH, Lee WC.

Transplant Proc. 2012 Apr;44(3):784-6. doi: 10.1016/j.transproceed.2012.03.028.

PMID:
22483495
18.

Risk factors and clinical outcomes of ventilator-associated pneumonia in patients on the liver transplant waiting list.

Cheng CH, Lee CF, Soong RS, Wu TH, Chan KM, Chou HS, Wu TJ, Yu MC, Lee WC.

Transplant Proc. 2012 Apr;44(3):762-4. doi: 10.1016/j.transproceed.2012.03.030.

PMID:
22483489
19.

Bortezomib is effective to treat acute humoral rejection after liver transplantation.

Lee CF, Eldeen FZ, Chan KM, Wu TH, Soong RS, Wu TJ, Chou HS, Lee WC.

Transplant Proc. 2012 Mar;44(2):529-31. doi: 10.1016/j.transproceed.2012.01.051.

PMID:
22410063
20.

"Left at right" adult liver transplantation: the feasibility of heterotopic implantation of left liver graft.

Chan KM, Eldeen FZ, Lee CF, Wu TJ, Chou HS, Wu TH, Soong RS, Lee WC.

Am J Transplant. 2012 Jun;12(6):1511-8. doi: 10.1111/j.1600-6143.2012.03997.x. Epub 2012 Mar 5.

Supplemental Content

Loading ...
Support Center